Webinars
-
Overcome The Hidden Complexities Of mRNA Process Development
3/22/2023
Explore the challenges behind the perceived simplicity of mRNA process development, as well as characterization strategies and models for predicting process outcomes at early stages.
-
How mRNA Manufacturers Disrupt The Industry
3/21/2023
Learn how biopharmaceutical companies can apply proven strategies to overcome hidden complexities in mRNA production, and discover solutions that can help you rapidly design and build a SU facility.
-
How A Sponsored CMC Platform Accelerates mRNA Projects Into The Clinic
1/31/2023
Developing a client-sponsored Target Product Profile (TPP) and Analytical Target Profile (ATP) is critical to move your drug product to clinic efficiently and meet acceptance criteria.
-
Forge A Successful CRISPR Therapeutic Path With High-Quality GMP sgRNA
1/19/2023
Learn how to accelerate your clinical timeline for cell and gene therapies and improve next-generation GMP production facilities.
-
Can A Small Plasmid Produce Huge Benefits? The Power Of Small
1/17/2023
With benefits across applications, nanoplasmids are designed to replace antiquated bacterial backbones, while eliminating antibiotic markers that can cause regulatory concerns.
-
Analyzing COVID-19 Vaccine Purity Using LC-MS Technologies
11/8/2022
Explore why process-related impurities are a concern in vaccines and present results and learnings from LC-MS analyses of several mRNA- and protein-based vaccines for COVID-19.
-
RNA Interference - From Single Gene Studies To Whole Genome Screens
11/7/2022
Endoribonuclease-prepared siRNAs (esiRNAs) are able to overcome the limitations of RNAi. Learn about esiRNAs, their advantages over standard siRNAs, and ways this technology is utilized in different research fields.
-
A&M STABTEST Shares QC Analysis Of Oligo Therapeutics
9/20/2022
Explore best practices for developing a QC method for identification and impurity analysis of oligonucleotides, as well as tips on mitigating risk by using compliant instrumentation and software.
-
Select An Ion-Pairing Agent For Impurity Analysis Of Oligonucleotides
5/4/2022
Learn about method development considerations when selecting an appropriate ion-pairing agent and impurity analysis of dye-conjugated oligonucleotides.
-
Keys To Successful mRNA Manufacturing
4/26/2022
How can PCR-based technology accelerate mRNA development and manufacturing and design principles/critical parameters to enable the rapid development of lipids for RNA formulation?